Published in Gut on July 01, 1995
Functional heartburn: the stimulus, the pain, and the brain. Gut (2002) 1.51
Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease. Dig Dis Sci (2012) 1.49
Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg (2005) 1.40
Acid perfusion test: a useful test for evaluating esophageal acid sensitivity. Dig Dis Sci (2005) 1.40
Transient receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and ATP release in mouse oesophageal keratinocytes. J Physiol (2011) 1.37
Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2010) 1.33
Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut (2005) 1.29
Functional esophageal disorders. Gut (1999) 1.26
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04
Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr (2007) 1.03
Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease. Gut (1998) 1.01
Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol (2013) 0.97
Natural history of Barrett's esophagus. World J Gastroenterol (2012) 0.93
Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease. Dig Dis Sci (2005) 0.93
Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus. World J Gastroenterol (2011) 0.92
Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus. Dig Dis Sci (2012) 0.91
Gastroesophageal reflux in mechanically ventilated pediatric patients and its relation to ventilator-associated pneumonia. Crit Care (2009) 0.89
Multimodal pain stimulations in patients with grade B oesophagitis. Gut (2005) 0.89
Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire. J Neurogastroenterol Motil (2013) 0.87
Neuromuscular function of the human lower oesophageal sphincter in reflux disease and Barrett's oesophagus. Gut (2000) 0.85
Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus. Dig Dis Sci (1997) 0.83
Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain. World J Gastroenterol (2006) 0.82
Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia? Can J Gastroenterol Hepatol (2014) 0.82
Most GERD symptoms are not due to acid reflux in patients with very low 24-hour acid contact times. Dig Dis Sci (2004) 0.81
The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. J Gastroenterol (2006) 0.81
Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease. Long-term quality-of-life assessment and surgical outcome. Surg Endosc (2005) 0.80
Diagnosis of Gastroesophageal Reflux Disease Using Real-time Magnetic Resonance Imaging. Sci Rep (2015) 0.79
Pathophysiology of gastro-oesophageal reflux disease. Acta Otorhinolaryngol Ital (2006) 0.79
Endoscopic screening and surveillance for Barrett's esophagus--clinical implications. MedGenMed (2006) 0.78
Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application? Gut (2006) 0.78
Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. Neurogastroenterol Motil (2016) 0.77
Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors? Dig Dis Sci (2000) 0.77
Barostat or dynamic balloon distention test: which technique is best suited for esophageal sensory testing? Dis Esophagus (2011) 0.77
Esophageal mucosal sensitivity: possible links with clinical presentations in patients with erosive esophagitis and laryngopharyngeal reflux. Dig Dis Sci (2007) 0.77
The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment. Gastroenterol Res Pract (2011) 0.76
Prolapse gastropathy syndrome may be a predictor of pathologic acid reflux. World J Gastroenterol (2008) 0.75
In GERD patients, mucosal repair associated genes are upregulated in non-inflamed oesophageal epithelium. J Cell Mol Med (2008) 0.75
Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients. World J Gastroenterol (2015) 0.75
Esophageal epithelial surface in patients with gastroesophageal reflux disease: an electron microscopic study. World J Gastroenterol (2008) 0.75
Impairment of secondary peristalsis in Barrett's esophagus by transnasal endoscopy-based testing. World J Gastroenterol (2014) 0.75
Acid and the esophagus. Yale J Biol Med (2000) 0.75
Managing Barrett's esophagus with radiofrequency ablation. Gastroenterol Rep (Oxf) (2013) 0.75
Brain activity following esophageal acid infusion using positron emission tomography. World J Gastroenterol (2010) 0.75
Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis. World J Gastroenterol (2012) 0.75
Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls. J Neurogastroenterol Motil (2016) 0.75
Intravenous Corticotropin-releasing Hormone Administration Increases Esophageal Electrical Sensitivity in Healthy Individuals. J Neurogastroenterol Motil (2017) 0.75
Visceral sensitivity in gastroesophageal reflux. Dig Dis Sci (2002) 0.75
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut (1973) 4.28
Patterns of gastroesophageal reflux in health and disease. Ann Surg (1976) 4.07
The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol (1988) 3.53
Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75
The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology (1991) 2.45
Reproducibility of ambulatory oesophageal pH monitoring. Gut (1988) 1.97
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci (1988) 1.91
Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology (1987) 1.88
Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology (1986) 1.87
Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology (1990) 1.81
The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci (1993) 1.75
The irritable oesophagus--a frequent cause of angina-like pain. Lancet (1987) 1.65
Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut (1987) 1.60
Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology (1987) 1.52
Symptom index as a marker of gastro-oesophageal reflux disease. Br J Surg (1992) 1.50
Enhanced perception of physiological intestinal motility in the irritable bowel syndrome. Gastroenterology (1991) 1.29
Natural history of benign esophageal stricture treated by dilatation. Gastroenterology (1983) 1.27
Barrett's esophagus: what's new and what to do. Am J Gastroenterol (1989) 1.01
Chest pain as a consequence of abnormal visceral nociception. Dig Dis Sci (1993) 0.98
Twenty-four-hour oesophageal pH monitoring: advances and controversies. Neth J Med (1989) 0.96
Functional relationships between cricopharyngeal sphincter and oesophageal body in response to graded intraluminal distension. Gut (1988) 0.89
Site and mechanism of pain perception with oesophageal balloon distension and intravenous edrophonium in patients with oesophageal chest pain. Gut (1992) 0.87
Hours, volume, and type of work of preregistration house officers. BMJ (1990) 5.68
Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption. Br Med J (1973) 3.77
Functional gastroduodenal disorders. Gut (1999) 3.74
The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol (1973) 3.26
Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91
Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther (1978) 2.41
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol (1975) 2.18
Techniques and errors in scintigraphic measurements of gastric emptying. J Nucl Med (1978) 2.10
Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet (1979) 2.06
Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut (1992) 1.96
Gastric emptying rate measurement in man. A double isotope scanning technique for simultaneous study of liquid and solid components of a meal. Gastroenterology (1976) 1.86
An evaluation of indium DTPA chelate in the measurement of gastric emptying by scintiscanning. Gut (1971) 1.85
Daytime gastro-oesophageal reflux is important in oesophagitis. Gut (1987) 1.72
Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci (1995) 1.69
Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Br Med J (1974) 1.63
Resolution of primary pneumatosis coli. J R Coll Surg Edinb (1978) 1.52
The oesophagus as a cause of recurrent chest pain: which patients should be investigated and which tests should be used? Lancet (1985) 1.48
Dynamic imaging of the stomach by real-time ultrasound--a method for the study of gastric motility. Gut (1980) 1.46
Influence of cholecystectomy on sphincter of Oddi motility. Gut (1997) 1.45
Radionuclide transit studies in the detection of oesophageal dysmotility. Gut (1983) 1.45
Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut (1979) 1.43
Relationships of human antroduodenal motility and transpyloric fluid movement: non-invasive observations with real-time ultrasound. Gut (1984) 1.34
Dermatitis herpetiformis: diagnosis, diet and demography. Gut (1984) 1.28
Functional esophageal disorders. Gut (1999) 1.26
Small-intestinal immunoglobulin levels in dermatitis herpetiformis. Lancet (1972) 1.24
Abnormal cardiovascular reflexes in patients with gastro-oesophageal reflux. Gut (1989) 1.23
Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther (2002) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
High flow oxygen therapy for pneumatosis coli. Gut (1979) 1.18
Abnormal gastric emptying in primary anorexia nervosa. Br J Psychiatry (1981) 1.14
Effect of nifedipine on oesophageal motility and gastric emptying. Digestion (1981) 1.13
Gastric emptying of solids in man. Gut (1982) 1.12
Gastroesophageal reflux and posterior laryngitis. Ann Otol Rhinol Laryngol (1989) 1.11
Comparison of intravenous edrophonium and oesophageal acid perfusion during oesophageal manometry in patients with non-cardiac chest pain. Gut (1988) 1.10
Pharyngoesophageal dysmotility in globus sensation. Arch Otolaryngol Head Neck Surg (1989) 1.10
Clinical spectrum of "solitary ulcer" of the rectum. Gastroenterology (1983) 1.08
Gastric emptying in diabetic autonomic neuropathy. Gut (1977) 1.07
Epidemiology of gastro-esophageal reflux disease. World J Surg (1992) 1.06
Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum (2000) 1.03
Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.01
Clinical response of dermatitis herpetiformis skin lesions to a gluten-free diet. Br J Dermatol (1976) 1.01
Swallowing performance in patients with vocal fold motion impairment. Dysphagia (1995) 1.01
Hepatitis B: absence of transmission by gastrointestinal endoscopy. Br Med J (1978) 1.00
Persistent gastrointestinal bleeding due to angiodysplasia of the gut in von Willebrand's disease. Lancet (1976) 0.96
Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technol Assess (2013) 0.96
Transpyloric fluid movement and antroduodenal motility in patients with gastro-oesophageal reflux. Gut (1987) 0.95
Normal pharyngoesophageal motility. A study of 50 healthy subjects. Dig Dis Sci (1989) 0.95
Clinical value of radionuclide oesophageal transit measurement. Gut (1986) 0.93
Premedication for upper gastrointestinal endoscopy: a comparative study of flunitrazepam, diazepam and neuroleptanalgesia. Endoscopy (1978) 0.93
Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther (2003) 0.91
Intestinal spirochaetosis. Postgrad Med J (1994) 0.91
Oesophageal manometry during eating in the investigation of patients with chest pain or dysphagia. Gut (1989) 0.90
Nature and standards of gastrointestinal and liver services in the United Kingdom. Gut (1993) 0.90
The effect of posture on errors in gastric emptying measurements. Phys Med Biol (1980) 0.90
The effects of age, sex, and smoking on normal pharyngoesophageal motility. Am J Gastroenterol (1990) 0.89
Serum IgA in the neonate. Molecular size, concentration and effect of breast feeding. Acta Paediatr Scand (1979) 0.89
Validation of a brief symptom questionnaire (ReQuest in Practice) for patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2008) 0.89
Globus sensation is not due to gastro-oesophageal reflux. Clin Otolaryngol Allied Sci (1987) 0.89
Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy. Am J Gastroenterol (1999) 0.89
Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci (1995) 0.88
Ruptured angiomatous spleen presenting as a severe coagulation defect. Br J Surg (1972) 0.88
Changes in absorptive and peptide hydrolase activities in rat small intestine after administration of 5-fluorouracil. Clin Sci Mol Med (1978) 0.88
A single scan technique for estimating acid output. Gastroenterology (1979) 0.88
The effect of histamine (H2-) receptor blockade on vagally-induced gastric secretion in man. Scott Med J (1974) 0.88
Small-intestinal bacterial flora in dermatitis herpetiformis. Am J Dig Dis (1974) 0.88
Duodenogastric reflux. Gut (1983) 0.87
Effect of histamine H2-receptor blockade on gastric emptying and serum gastrin in man. Scott Med J (1976) 0.87
Site and mechanism of pain perception with oesophageal balloon distension and intravenous edrophonium in patients with oesophageal chest pain. Gut (1992) 0.87
Effect of omeprazole on lower oesophageal function in normal subjects. Aliment Pharmacol Ther (1987) 0.87
Acetaminophen absorption and metabolism in celiac disease and Crohn's disease. Clin Pharmacol Ther (1981) 0.87
Purpura and paracetamol. Br Med J (1968) 0.86
Systematic comparison of conventional oesophageal manometry with oesophageal motility while eating bread. Gut (1991) 0.86
Salicylate induced exacerbation of ulcerative colitis. Gut (1987) 0.86
Gastric emptying: a clinical perspective. Clin Sci (Lond) (1982) 0.86
Abnormal transient internal sphincter relaxation in idiopathic pruritus ani: physiological evidence from ambulatory monitoring. Br J Surg (1994) 0.86
Protein-losing enteropathy in dermatitis herpetiformis. Br J Dermatol (1973) 0.85
A new radioisotopic technic for the measurement of gastric emptying time of solid meal. Am J Gastroenterol (1976) 0.84
Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Vaccine (1989) 0.83
Effect of the histamine H2-receptor antagonist, cimetidine, on gastric secretion and serum gastrin during insulin infusion in Man. Scand J Gastroenterol (1976) 0.82